News

Check all IrsiCaixa scientific news in just one click.

SARS-CoV-2

Therapies

10/07/2022

Study shows that adding a new antiviral to current COVID-19 treatment could reduce mortality in hospitalised patients by 30%

HIV

SARS-CoV-2

07/07/2022

Three IrsiCaixa female researchers receive funding from Gilead to keep progressing in the field of HIV and COVID-19

Alumni

28/06/2022

The IAN Talks are back, the meeting point for IrsiCaixa alumni

Therapies

27/06/2022

Common antiretroviral drug improves cognition in mouse model of Down syndrome

Microbiome

SARS-CoV-2

HIV

26/06/2022

Predicting the progression of SARS-CoV-2 and HIV infection by studying the microbiome

SARS-CoV-2

Prevention

22/06/2022

CPC in mouthwashes is shown in humans to break the membrane of SARS-CoV-2 and reduce the amount of active virus in saliva

Living Lab for Health

15/06/2022

2nd Sentinel Schools Congress: health research with and for the educational community

web_-_javier_m._picado.jpg

Achievement

30/05/2022

IrsiCaixa researcher Javier Martínez-Picado, new elected member of the Royal Academy of Sciences and Arts of Barcelona

SARS-CoV-2

Vaccines

17/05/2022

RBDCOV initiates the first Phase III clinical trial of HIPRA's COVID-19 vaccine in immunocompromised people